# Complement and diverse enrichment of antibodies in intraluminal thrombi from abdominal aortic aneurysms may contribute to increased inflammation

**Authors:** Vibeke Videm, Animesh Sharma, Torbjørn Dahl

PMC · DOI: 10.1038/s41598-025-29506-0 · Scientific Reports · 2025-11-29

## TL;DR

This study shows that immune components like complement and antibodies are enriched in blood clots from abdominal aortic aneurysms, suggesting they may drive inflammation and aneurysm progression.

## Contribution

The study reveals novel evidence of complement activation and diverse antibody enrichment in intraluminal thrombi from AAA.

## Key findings

- Complement activation via classical and lectin pathways was observed in intraluminal thrombi.
- ILT showed 151 heavy and 144 light chain antibody variable regions, compared to 25 and 26 in controls.
- Immunohistochemistry confirmed IgG, IgM, and IgA presence along with terminal complement activation in ILT.

## Abstract

Abdominal aortic aneurysms (AAA) often contain an intraluminal thrombus (ILT) which may contribute to aneurysm growth and rupture, but the mechanisms are not well understood. We hypothesized that complement and antibodies play a central role in the immune reactions within ILT from AAA. We quantified pre-specified proteins from complement and other defense systems, including coagulation, fibrinolysis, neutrophils, relevant proteinases and inhibitors, as well as immunoglobulins in ILT (n = 7), using fresh thrombi for comparison (n = 7). Protein analysis was performed using liquid chromatography in tandem with mass spectrometry, permitting simultaneous protein detection with comparable quantitative results, and antibody diversity characterization. The results indicated complement activation (classical and lectin pathways), coagulation (contact pathway), and degranulation including proteinase release from neutrophils in the ILT, with protein enrichment compared to fresh thrombi. Inhibitors of these systems were also present. In the ILT, 151 different immunoglobulin heavy chain and 144 different light chain variable regions were detected. Corresponding numbers in the controls were 25 and 26. Immunohistochemistry confirmed terminal complement activation and substantial presence of IgG in the ILT, which also contained IgM and IgA. These results are suggestive of a complex immunological process with activation of many defense systems, and antibody enrichment in the ILT.

The online version contains supplementary material available at 10.1038/s41598-025-29506-0.

## Linked entities

- **Proteins:** IGG (Immunoglobulin G level), CD40LG (CD40 ligand), CD79A (CD79a molecule)
- **Diseases:** AAA (MONDO:0009279)

## Full-text entities

- **Genes:** CD79A (CD79a molecule) [NCBI Gene 973] {aka IGA, IGAlpha, MB-1, MB1}
- **Diseases:** rupture (MESH:D012421), thrombus (MESH:D013927), AAA (MESH:D017544), inflammation (MESH:D007249), aneurysm (MESH:D000783)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12770350/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12770350/full.md

## References

2 references — full list in the complete paper: https://tomesphere.com/paper/PMC12770350/full.md

---
Source: https://tomesphere.com/paper/PMC12770350